Clinical Trial Update: Treatment of Optic Neuritis With Erythropoietin: a Randomised, Double-blind, Placebo-controlled Trial [Phase 3]

View source ↗

Summary

A Phase 3 randomized, double-blind, placebo-controlled trial evaluating erythropoietin for optic neuritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Optic Neuritis

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: University Eye Hospital, Freiburg | Conditions: Optic Neuritis | Phase 3 | Status: COMPLETED